Nihar R. Pandey, Ph.D.

President & CEO

Dr. Pandey is the founding President and CEO of Anthem Pharmaceuticals Inc. He founded Medipure Pharmaceuticals Inc. in 2014 and has been working as Chief Scientific Officer and CEO. He is the Chief Scientific Officer at CliniCan Health Research and Paws Pharma, both in Canada. Dr. Pandey has a Ph.D. in Clinical Biochemistry and with more than 25 years of life sciences and pharmaceuticals R&D and business development. He is considered one of the KOLs in drug discovery, development, and approval of therapeutics in metabolic disease (diabetes, obesity, cardiovascular), neuroscience, dermatology, and endocannabinoid with a Concept-to-Market approach.

He has received postdoctoral training from the Department of Medicine, University of Montreal, Clinical Research Institute of Montreal, and McGill University, Canada. He was appointed as a Research Scientist at the University of Ottawa Heart Institute and The Ottawa Hospitals (OHRI-Neuroscience) and was a Group leader for Drug Discovery and Development at Liponex Inc. Ottawa, Canada. Nihar has received clinical research training and has worked for Health Canada in regulatory toxicology. He has published more than 35 peer-reviewed research papers, 5 active patents, and 2 book chapters. He also serves as a scientific reviewer in leading medical/life science journals including, Circulation, Circulation Research, The Lancet, Hypertension, Journal of Cell Biology, Lancet Diabetes, Molecular Neuroscience, Metabolism, etc. He has expertise in business development and R&D related to drugs and devices including controlled drug substances.

Rashmi Tiwari-Pandey, Ph.D.


Dr. Rashmi Tiwari-Pandey is the Executive Vice President, Chief Scientific Officer, and Co-Founder of Anthem Pharmaceutical.  Prior to this, she was appointed as Director for Clinical Studies and Preclinical Development at Medipure Pharmaceuticals. At present, she is also serving as President of CliniCan Health Research.

She has a Ph.D. in Endocrinology, with expertise in clinical and regulatory affairs (CCRP). She has extensive R&D and Pharma experience and is a leader in Clinical and Regulatory affairs.  Her therapeutic area of expertise includes Cancer Research, Menopause-related disorders, Hormone Replacement Therapy, Osteoporotic Bone Loss, Regenerative medicine, and Biomaterial-assisted biotherapy.

She is responsible for promoting our business concept as a CRO for cutting-edge R&D services, including collaborative and interdisciplinary research between our clients. This role works to develop networking between Anthem Pharmaceuticals and industry researchers in the public and private sectors locally, nationally, and internationally. She also acts as a nexus between Anthem Pharmaceuticals and the physician community with respect to research and clinical initiatives of cooperation.

Bao Li


Bao Li is the Chief Operating Officer, Chief Information Officer, and Co-Founder of Anthem Pharmaceuticals.  As COO and CIO, Bao is charged with ensuring smooth daily company operations and maintaining IT systems.

With over 25 years of experience, Bao has experience in various industries such as the Federal Government, Oil and Gas, Ship Building, and Pharmaceutical R&D.  Bao has spent over 12 years with Seaspan ULC in various roles and prior to the creation of Anthem Pharmaceuticals, he served as the IT Manager of Medipure Pharmaceuticals.

In his spare time, Bao likes to keep up to date with the latest tech innovations and taking long road trips.  As an avid car lover, one of his current weekend projects converting his Toyota MR2 Turbo to run on an electric drivetrain.